Please login to the form below

Listeria monocytogenes

This page shows the latest Listeria monocytogenes news and features for those working in and with pharma, biotech and healthcare.

Advaxis shaken by another FDA hold on cervical cancer vaccine

Axal is a targeted Listeria monocytogenes (Lm)-based immunotherapy that attacks HPV-associated cancers by altering a live strain of Lm bacteria to generate cancer-fighting T cells against cancer antigens

Latest news

Amgen enters into $540m immunotherapy collaboration

Listeria monocytogenes (Lm) technology to create a tailored cancer treatment.
Listeria-based vaccine could halt breast cancer

The vaccine was developed from investigations into the Listeria monocytogenes bacterium which grows in milk, cheese and other dairy products. ... Listeria blocks the immune system's response when it gains access to the body, helping it to spread.

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

Pharma deals during October 2014

on Aduro's novel LADD [live-attenuated double-deleted Listeria monocytogenes strains that have been engineered to induce an innate immune response] immunotherapy platform.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

The big issue: Whether you want to lead or follow, you need to understand the elephant in the C-suite...
INFOGRAPHIC 02: The Importance of clinical study websites: Here’s a infographic of why clinical study websites are important to patient recruitment and retention strategies…...
Working with, Advocating for, and Empowering Patients: A holistic view of how to work with patients virtually...